Last edition
News about "CSE approval "
PharmaDrug Signs Definitive Agreement to Acquire Equity Interest in Canurta Inc
Under the Definitive Agreement, PharmaDrug will acquire up to a 40 percent equity interest in Canurta, to be completed in two tranches through the issuance of an aggregate of 83,645,316 common shares of PharmaDrug (PHRX Shares) at a deemed price equal to the 20-day volume-weighted average price immediately prior to each closing.
CSE Approval | 01/11/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members